These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1131721)

  • 1. Chemotherapeutic response of experimental solid tumors.
    Steel GG
    Can J Otolaryngol; 1975; 4(1):18-20. PubMed ID: 1131721
    [No Abstract]   [Full Text] [Related]  

  • 2. A methodological approach to the prediction of anticancer drug effect in humans.
    Durkin WJ; Ghanta VK; Balch CM; Davis DW; Hiramoto RN
    Cancer Res; 1979 Feb; 39(2 Pt 1):402-7. PubMed ID: 761212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
    Griswold DP
    Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116
    [No Abstract]   [Full Text] [Related]  

  • 4. [Strategy of antileukemic agents; the relationship between in vitro cell-killing kinetics and in vivo chemotherapeutic effects (author's transl)].
    Shimoyama M
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):695-706. PubMed ID: 4480564
    [No Abstract]   [Full Text] [Related]  

  • 5. An approach to tumour biology in the light of prevention, cure and etiology.
    Bose S; Chowdhury JR
    Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical chemotherapy: historical aspects.
    Goldin A
    Mt Sinai J Med; 1985 Jun; 52(6):419-25. PubMed ID: 3894946
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental models and their clinical correlations.
    Carter SK; Goldin A
    Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496
    [No Abstract]   [Full Text] [Related]  

  • 8. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
    Mihich E; Nichol CA
    Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
    [No Abstract]   [Full Text] [Related]  

  • 9. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapeutic characterization in mice of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfinamide (sulfinosine), a novel purine nucleoside with unique antitumor properties.
    Avery TL; Finch RA; Vasquez KM; Radparvar S; Hanna NB; Revankar GR; Robins RK
    Cancer Res; 1990 May; 50(9):2625-30. PubMed ID: 2328488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoplasia, kinetics, nd chemotherapy.
    Hart JS; Livingston RB; Murphy WK; Barlogie B; Gehan EA; Bodey GP
    Semin Oncol; 1976 Sep; 3(3):259-70. PubMed ID: 790580
    [No Abstract]   [Full Text] [Related]  

  • 13. The carcinostatic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone.
    Blanz EJ; French FA
    Cancer Res; 1968 Dec; 28(12):2419-22. PubMed ID: 5728150
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy: considerations for design and analysis.
    Lloyd HH
    Cancer Chemother Rep 2; 1974 Mar; 4(1):157-65. PubMed ID: 4826495
    [No Abstract]   [Full Text] [Related]  

  • 15. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical rationales for the selection of combinations of chemotherapeutic agents.
    Bono VH
    Cancer Chemother Rep 2; 1974 Mar; 4(1):131-6. PubMed ID: 4826492
    [No Abstract]   [Full Text] [Related]  

  • 17. A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.
    Ayash LJ; Antman K; Cheson BD
    Oncology (Williston Park); 1991 Mar; 5(3):25-33; discussion 33, 36, 41. PubMed ID: 1829944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
    Leiter J; Abbott BJ; Schepartz SA
    Cancer Res; 1965 Dec; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytosine arabinoside (NSC-63878)--clinical brochure.
    Livingston RB; Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):179-205. PubMed ID: 4989814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.